REVIEW
Published on 26 Jul 2022
Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges
doi 10.3389/fonc.2022.820128
- 9,830 views
- 16 citations
- Frontiers in Oncology
- Cancer Genetics
- Research Topics
- Identification of Genetic Changes and Targeted Therapies in Breast and Ovarian Cancers
Identification of Genetic Changes and Targeted Therapies in Breast and Ovarian Cancers
11k
Total downloads
41k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 16 May 2022
Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
doi 10.3389/fonc.2022.861392
- 2,270 views
- 5 citations
ORIGINAL RESEARCH
Published on 09 May 2022
A Crucial Angiogenesis-Associated Gene MEOX2 Could Be a Promising Biomarker Candidate for Breast Cancer
doi 10.3389/fonc.2022.759300
- 2,092 views
- 2 citations
ORIGINAL RESEARCH
Published on 01 Mar 2022
RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer
doi 10.3389/fonc.2022.830908
- 3,846 views
- 14 citations
SYSTEMATIC REVIEW
Published on 28 Jan 2022
Emerging Roles of m6A RNA Methylation Regulators in Gynecological Cancer
doi 10.3389/fonc.2022.827956
- 3,965 views
- 21 citations
ORIGINAL RESEARCH
Published on 12 Jan 2022
Next-Generation Sequencing Reveals a Very Low Prevalence of Deleterious Mutations of Homologous Recombination Repair Genes and Homologous Recombination Deficiency in Ovarian Clear Cell Carcinoma
doi 10.3389/fonc.2021.798173
- 3,325 views
- 9 citations
ORIGINAL RESEARCH
Published on 11 Jan 2022
Characterization of Synonymous BRCA1:c.132C>T as a Pathogenic Variant
doi 10.3389/fonc.2021.812656
- 3,126 views
ORIGINAL RESEARCH
Published on 16 Dec 2021
Inferring Homologous Recombination Deficiency of Ovarian Cancer From the Landscape of Copy Number Variation at Subchromosomal and Genetic Resolutions
doi 10.3389/fonc.2021.772604
- 3,835 views
- 3 citations
SYSTEMATIC REVIEW
Published on 24 Nov 2021
Comparison of the Efficacy and Safety of PARP Inhibitors as a Monotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis
doi 10.3389/fonc.2021.785102
- 7,109 views
- 8 citations
Published in
Frontiers in Oncology
- Cancer Genetics
- Gynecological Oncology
Impact
- 41kTopic views
- 28kArticle views
- 11kArticle downloads